OVERVIEW
The global primary cell market is expected to hit USD 1,453 million by 2025, increasing over the forecast period at a CAGR of 7.6%. Growth in the primary cell market is driven mainly by factors such as increased cancer research; the advantages of primary human cells over cell lines; growing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries; partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing.
TABLE OF CONTENT
1 Global Primary Cells Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Primary Cells Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Primary Cells Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Primary Cells Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Primary Cells Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Primary Cells Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Primary Cells Market – By Origin (Market Size – & million/billion)
8.1 Hematopoietic Cells
8.2 Skin Cells
8.3 Gastrointestinal Cells
8.4 Liver Cells
8.5 Lung Cells
8.6 Renal Cells
8.7 Heart Cells
8.8 Skeletal & Muscle Cells
8.9 Other
9 Global Primary Cells Market – By Type
9.1 Human Primary Cells
9.2 Animal Primary Cells
10 Global Primary Cells Market – By End User
10.1 Life Science Research Companies
10.2 Research Institutes
11 Global Primary Cells Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Primary Cells Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Primary Cells Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Zenbio
13.3 Promocell
13.4 Cell Biologics
13.5 Merck KGaA
13.6 Lonza
13.7 Thermo Fisher Scientific
13.8 American Type Culture Collection (ATCC)
13.9 ALLCells
13.10 Stem Cell Technologies
13.11 Axol Biosciences
13.12 Company 11 & more
14 Global Primary Cells Market – Appendix
14.1 Sources
14.2 Abbreviations